搜尋
產品
社群
市場
新聞
經紀商
更多
TW
立即開始
CRSP- Pioneer and leader in gene editing
CRISPR Therapeutics AG
(
NASDAQ:CRSP
)
Libratus
NASDAQ:CRSP
CRISPR Therapeutics AG
Trend Analysis
Technical Indicators
Fundamental Analysis
CRSP
crspr
geneediting
EDIT
NTLA
beam
2
0
trendanalysis
indicator
fundamental
crsp
crspr
geneediting
edit
ntla
beam
CRSP is the leader and pioneer of the CRISPR/CAS9 gene-editing breakthrough. It is a long-term bet as short-term to mid-term future is uncertain.
I think it has one more leg down. Accumulate in the demand zone.
相關想法
ILMN- Leader in gene sequencing
Libratus
about
ILMN
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款
閱讀更多資訊。